These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9950161)

  • 1. Telomerase activity in microdissected human gliomas.
    Weil RJ; Wu YY; Vortmeyer AO; Moon YW; Delgado RM; Fuller BG; Lonser RR; Remaley AT; Zhuang Z
    Mod Pathol; 1999 Jan; 12(1):41-6. PubMed ID: 9950161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningiomas, dicentric chromosomes, gliomas, and telomerase activity.
    Carroll T; Maltby E; Brock I; Royds J; Timperley W; Jellinek D
    J Pathol; 1999 Aug; 188(4):395-9. PubMed ID: 10440750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase in brain tumors.
    Falchetti ML; Larocca LM; Pallini R
    Childs Nerv Syst; 2002 Apr; 18(3-4):112-7. PubMed ID: 11981616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
    Mukai S; Kondo Y; Koga S; Komata T; Barna BP; Kondo S
    Cancer Res; 2000 Aug; 60(16):4461-7. PubMed ID: 10969793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide synthase expression and enzymatic activity in human brain tumors.
    Broholm H; Rubin I; Kruse A; Braendstrup O; Schmidt K; Skriver EB; Lauritzen M
    Clin Neuropathol; 2003; 22(6):273-81. PubMed ID: 14672505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of clinical features and telomerase activity in human gliomas.
    Huang F; Kanno H; Yamamoto I; Lin Y; Kubota Y
    J Neurooncol; 1999 Jun; 43(2):137-42. PubMed ID: 10533725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase as a therapeutic target for malignant gliomas.
    Komata T; Kanzawa T; Kondo Y; Kondo S
    Oncogene; 2002 Jan; 21(4):656-63. PubMed ID: 11850793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
    Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
    Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas.
    Morii K; Tanaka R; Onda K; Tsumanuma I; Yoshimura J
    Biochem Biophys Res Commun; 1997 Oct; 239(3):830-4. PubMed ID: 9367854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase activity in human brain tumors.
    Röhn G; Ernestus RI; Schröder R; Hossmann KA; Klug N; Paschen W
    Acta Histochem Suppl; 1992; 42():155-8. PubMed ID: 1350103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].
    Wang DL; Wang YF; Shi GS; Huang H
    Ai Zheng; 2007 Jun; 26(6):601-6. PubMed ID: 17562265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma.
    Shervington A; Patel R; Lu C; Cruickshanks N; Lea R; Roberts G; Dawson T; Shervington L
    Brain Res; 2007 Feb; 1134(1):45-52. PubMed ID: 17196947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in central nervous system malignant lymphoma.
    Harada K; Kurisu K; Arita K; Sadatomo T; Tahara H; Tahara E; Ide T; Uozumi T
    Cancer; 1999 Sep; 86(6):1050-5. PubMed ID: 10491533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isozymes of pyruvate kinase from human brain, meningiomas, and malignant gliomas.
    van Veelen CW; Verbiest H; Vlug AM; Rijksen G; Staal GE
    Cancer Res; 1978 Dec; 38(12):4681-7. PubMed ID: 214230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas.
    Viapiano MS; Bi WL; Piepmeier J; Hockfield S; Matthews RT
    Cancer Res; 2005 Aug; 65(15):6726-33. PubMed ID: 16061654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential hTERT mRNA processing between young and older glioma patients.
    Shervington A; Patel R
    FEBS Lett; 2008 May; 582(12):1707-10. PubMed ID: 18435920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of prognostic markers in brain tumors.
    Grzybicki DM; Moore SA
    Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
    Ito H; Aoki H; Kühnel F; Kondo Y; Kubicka S; Wirth T; Iwado E; Iwamaru A; Fujiwara K; Hess KR; Lang FF; Sawaya R; Kondo S
    J Natl Cancer Inst; 2006 May; 98(9):625-36. PubMed ID: 16670388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.